Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PAVmed Inc.PAVM · Entity 7317 | Chief Medical Officer | February 18, 2022 | February 24, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PAVmed Inc.
Report date February 18, 2022 · Filed February 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.59 · Expires 2032-02-18 | Direct | 50,000 |
Reported balance
After 2022-02-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-02-18 · Grant · Acquired 50,000 · Balance 50,000 F1: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2022 Filed Feb 24, 2022 01:25 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee stock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001062993-22-005492 · form4.xml · derivative · entry 1 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:15 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001094891-21-000168 · edgar.xml · derivative · entry 1 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-04-01 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on September 30, 2021. Read SEC document |
| April 30, 2020 Filed May 4, 2020 22:02 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001094891-20-000074 · edgar.xml · derivative · entry 1 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-04-30 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on June 30, 2020. Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 01:19 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001094891-19-000085 · edgar.xml · derivative · entry 1 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-03-07 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2019. Read SEC document |
| June 26, 2018 Filed Jul 12, 2018 19:49 UTC | PAVmed Inc. PAVM · Entity 7317 | OtherSeries Z Warrants · Derivative | 322,673 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001094891-18-000156 · edgar.xml · derivative · entry 2 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 0 Underlying: Common Stock · 322,673 shares Expires 2024-04-30 F2 · kind: Contribution to Pavilion Venture Partners LLC, of which the trust is a non-managing member. Read SEC document |
| June 26, 2018 Filed Jul 12, 2018 19:49 UTC | PAVmed Inc. PAVM · Entity 7317 | OtherSeries Z Warrants · Derivative | 322,673 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001094891-18-000156 · edgar.xml · derivative · entry 1 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 322,673 Underlying: Common Stock · 322,673 shares Expires 2024-04-30 F1 · kind: Pro rata distribution from HCFP/Capital Partners III LLC, of which the trust is a non-managing member. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 21:25 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001094891-18-000048 · edgar.xml · derivative · entry 1 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-02-14 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2018. Read SEC document |
| December 21, 2017 Filed Jan 3, 2018 22:36 UTC | PAVmed Inc. PAVM · Entity 7317 | OtherCommon Stock | 645,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-18-000021 · edgar.xml · nonDerivative · entry 2 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 0 F2 · kind: Contribution to Pavilion Venture Partners LLC, of which the trust is a non-managing member. Read SEC document |
| December 21, 2017 Filed Jan 3, 2018 22:36 UTC | PAVmed Inc. PAVM · Entity 7317 | OtherCommon Stock | 645,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-18-000021 · edgar.xml · nonDerivative · entry 1 DeGuzman Brian J. · CIK 0001664813 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 645,346 F1 · kind: Pro rata distribution from HCFP/Capital Partners III LLC, of which the trust is a non-managing member. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.